Miller Anestesia

Guidelines (8th Edition). Chest 133(6Suppl):

381S–453S, 2008.

236. Ernst E, Matrai A: Abstention from chronic ciga-

rette smoking normalizes blood rheology. Atheros-

clerosis 64:75, 1987.

237. Bluman LG, Mosca L, Newman N, Simon DG:

Preoperative smoking habits and postoperative

pulmonary complications. Chest 113:883–889,

1998.

238. Nakagawa M, Tanaka H, Tsukuma H, Kishi Y: Rela-

tionship between the duration of the preoperative

smoke-free period and the incidence of postopera-

tive pulmonary complications after pulmonary

surgery. Chest 120:705–710, 2001.

239. Warner DO: Perioperative abstinence from cigaret-

tes: Physiologic and clinical consequences. Anes-

thesiology 104:356–367, 2006.

240. Quraishi SA, Orkin FK, Roizen MF: The anesthesia

preoperative assessment: An opportunity for

smoking cessation intervention. J Clin Anesth

18:635–640, 2006.

241. McCreanor J, Cullinan P, Nieuwenhuijsen MJ, et al:

Respiratory effects of exposure to diesel traffic in

persons with asthma. N Engl J Med 357:2348–2358,

2007.

242. Downs SH, Schindler C, Liu LJS, et al: Reduced

exposure to PM10 and attenuated age-related

decline in lung function. N Engl J Med 357:2338–

2347, 2007.

243. Celli BR, Rodriguez KS, Snider GL: A controlled

trial of intermittent positive pressure breathing,

incentive spirometry, and deep breathing exerci-

ses in preventing pulmonary complications after

abdominal surgery. Am Rev Respir Dis 130:12,

1984.

244. Bartlett RH, Brennan ML, Gazzaniga AB, et al:

Studies on the pathogenesis and prevention of

postoperative pulmonary complications. Surg

Gynecol Obstet 137:925, 1973.

245. Lyager S, Wernberg M, Rajani N, et al: Can posto-

perative pulmonary conditions be improved by

treatment with the Bartlett-Edwards incentive spi-

rometer after upper abdominal surgery? Acta

Anaesthesiol Scand 23:312, 1979.

246. Elwood T, Morris W, Martin LD, et al: Bronchodila-

tor premedication does not decrease respiratory

adverse events in pediatric general anesthesia. Can

J Anaesth 50:277–284, 2003.

247. Boushy SF, Billing DM, North LB, et al: Clinical

course related to preoperative pulmonary function

in patients with bronchogenic carcinoma. Chest

59:383, 1971.

248. Mittman C:Assessment of operative risk in thoracic

surgery. Am Rev Respir Dis 84:197, 1961.

249. Reichel J: Assessment of operative risk of pneumo-

nectomy. Chest 62:570, 1972.

250. Wong DH, Weber EC, Schell MJ, et al: Factors

associated with postoperative pulmonary compli-

cations in patients with severe COPD. Anesth

Analg 80:276, 1995.

251. Arozullah AM, Daley J, Henderson WG, Khuri SF:

Multifactorial risk index for predicting postopera-

tive respiratory failure in men after major noncar-

diac surgery. The National Veterans Administration

Surgical Quality Improvement Program. Ann Surg

232:242–253, 2000.

252. Arozullah AM, Khuri SF, Henderson WG, et al:

Development and validation of a multifactorial risk

index for predicting postoperative pneumonia after

major noncardiac surgery. Ann Intern Med

135:847–857, 2001.

253. Kabalin CS, Yarnold PR, Grammer LC: Low com-

plication rate of corticosteroid-treated asthmatics

undergoing surgical procedures. Arch Intern Med

155:1379–1384, 1995.

254. Selzer A, Walter RM: Adequacy of preoperative

digitalis therapy in controlling ventricular rate in

postoperative atrial fibrillation. Circulation 34:119,

1966.

255. Geerts WH, Heit JA, Clagett GP, et al: Prevention of

venous thromboembolism. Chest 119(1 Suppl)

132S–175S, 2001.

256. O’Donnell M, Weitz JI: Thromboprophylaxis in

surgical patients. Can J Surg 46:129–135, 2003.

257. Matthay RA, Niederman MS, Wiedemann HP:

Cardiovascular pulmonary interaction in chronic

obstructive pulmonary disease with special refe-

rence to pathogenesis and management of cor

pulmonale. Med Clin North Am 74:571, 1990.

258. Fedullo PF,Auger WR, Kerr KM, Rubin LJ: Chronic

thromboembolic pulmonary hypertension. N Engl

J Med 345:1465–1472, 2001.

259. Galie N, Ghofrani HA, Torbicki A, et al: Sildenafil

citrate therapy for pulmonary arterial hypertension.

N Engl J Med 353:2148–2157, 2005.

260. Domino KB,Wetstein L, Glasser SA, et al: Influence

of mixed venous oxygen tension on blood flow to

atelectatic lung. Anesthesiology 59:428, 1983.

261. Settipane GA, Dudupakkam RK: Aspirin intole-

rance. III: Subtypes, familial occurrence and cross

reactivity with tartrazine. J Allergy Clin Immunol

56:215, 1975.

262. Cancer Statistics for the United States. Available at

www.cdc.gov/nchs/products/pubs/pubd/hus/ trendtables.htm

200.

263. Aisner J: Extensive-disease small-cell lung cancer:

The thrill of victory the agony of defeat. J Clin

Oncol 14:658, 1996.

264. Cooper JAD (ed). Drug-induced pulmonary

disease. Clin Chest Med 11:1, 1990.

265. Levy JH, Roizen MF, Morris JM: Anaphylactic and

anaphylactoid reactions: A review. Spine 11:282,

1986.

266. Kemp SF, Lockey RF: Anaphylaxis: A review of

causes and mechanisms. J Allergy Clin Immunol

110:341–348, 2002.

267. Smith PL, Kagey-Sobotka A, Bleecker ER, et al:

Physiologic manifestations of human anaphylaxis. J

Clin Invest 66:1072, 1980.

268. Delage C, Irey NS: Anaphylactic deaths: A clinico-

pathologic study of 43 cases. J Forensic Sci 17:525,

1972.

269. Bettman MA: Radiographic contrast agents—a

perspective. N Engl J Med 317:891, 1987.

270. Roizen MF, Rodgers GM, Valone FH, et al: Ana-

phylactoid reactions to vascular graft material pre-

senting with vasodilation and subsequent

disseminated intravascular coagulation. Anesthe-

siology 71:331, 1989.

271. Mertes PM, Laxenaire MC: Allergic reactions occu-

rring during anaesthesia. Eur J Anaesthesiol

19:240–262, 2002.

272. Lieberman P: Anaphylactic reactions during surgi-

cal and medical procedures.J Allergy Clin Immunol

110(2 Suppl)S64–S69, 2002.

273. Rosow CE, Moss J, Philbin DM, et al: Histamine

release during morphine and fentanyl anesthesia.

Anesthesiology 56:93, 1982.

274. Millbern SM, Bell SD: Prevention of anaphylaxis to

contrast media. Anesthesiology 50:56, 1979.

275. Halevy S, Altura BT, Altura BM: Pathophysiological

basis for the use of steroids in the treatment of

shock and trauma. Klin Wochenschr 60:1021,

1982.

276. Toogood JH: Risk of anaphylaxis in patients recei-

ving beta-blocker drugs. J Allergy Clin Immunol

81:1, 1988.

277. Van Arsdel PP Jr, Larson EB: Diagnostic tests for

patients with suspected allergic disease. Ann Intern

Med 110:304, 1989.

278. Heyland DK, Novak F, Drover JW, et al: Should

immunonutrition become routine in critically ill

patients? A systematic review of the evidence.

JAMA 286:944–953, 2001.

279. Drugs for epilepsy. Med Lett Drugs Ther 45, 57–64,

2003.

280. Roberts R: Differential diagnosis of sleep disorders,

non-epileptic attacks and epileptic attacks. Curr

Opin Neurol 11:135–139, 1998.

281. Shaner DM, McCurdy SA, Herring MO, et al:

Treatment of status epilepticus: A prospective

comparison of diazepam and phenytoin versus

phenobarbital and optional phenytoin. Neurology

38:202, 1988.

282. Schuchat A, Robinson K,Wenger JD, et al: Bacterial

meningitis in the United States in 1995. N Engl J

Med 337:970, 1997.

283. Parkinson Study Group: Impact of deprenyl and

tocopherol treatment on Parkinson’s disease in

DATA TOP patients requiring levodopa. Ann

Neurol 39:37, 1996.

284. Goetz CG, Olanow CW, Koller WC, et al: Multicen-

ter study of autologous adrenal medullary trans-

plantation to the corpus striatum in patients with

advanced Parkinson’s disease.N Engl J Med 320:337,

1989.

285. Mets B: Acute dystonia after alfentanil in untreated

Parkinson’s disease. Anesth Analg 72:557, 1991.

286. Muzzi DA, Black S, Cucchiara RF: The lack of effect

of succinylcholine on serum potassium in patients

with Parkinson’s disease. Anesthesiology 71:322,

1989.

287. Wiklund RA, Ngai SH: Rigidity and pulmonary

edema after Innovar in a patient on levodopa

therapy: Report of a case. Anesthesiology 35:545–

547, 1971.

288. Barry PP, Moskowitz MA: The diagnosis of reversi-

ble dementia in the elderly, a critical review. Arch

Intern Med 148:1914, 1988.

289. Skoog I, Nilsson J, Palmertz B, et al: A population-

based study of dementia in 85-year-olds. N Engl J

Med 328:153, 1993.

290. Petersen RC, Smith GE, Waring SC, et al: Mild

cognitive impairment: Clinical characterization and

outcome. Arch Neurol 56:303–308, 1999.

291. Ross GW,Abbott RD, Petrovitch H, et al: Frequency

and characteristics of silent dementia among elderly

Japanese-American men. The Honolulu-Asia Aging

Study. JAMA 277:800, 1997.

292. Snowdon DA, Greiner LH, Mortimer JA, et al: Brain

infarction and the clinical expression of Alzheimer

disease. The Nun Study. JAMA 277:813, 1997.

293. Drugs for Alzheimer’s disease. Med Lett Drugs Ther

43:53, 2001.

294. Jones PM,Soderman RM: Intra-operative bradycar-

dia in a patient with Alzheimer’s disease treated

with two cholinesterase inhibitors. Anaesthesia

62:201, 2007.

295. Xie Z, Tanzi RE: Alzheimer’s disease and post-ope-

rative cognitive dysfunction. Exp Gerontol 41:346–

359, 2006.

296. Eckenhoff RG, Johansson JS, Wei H, et al: Inhaled

anesthetic enhancement of amyloid-beta oligomeri-

zation and cytotoxicity. Anesthesiology 101:703–

709, 2004.

297. Wei H, Liang G, Wang Q, et al: The common inha-

lational anesthetic isoflurane induces apoptosis via

activation of inositol 1,4,5-trisphosphate receptors.

Anesthesiology 108:251–260, 2008.

298. Zhang B, Dong Y, Zhang G, et al: The inhalation

anesthetic desflurane induces caspase activation

and increases amyloid beta-protein levels under

hypoxic conditions. J Biol Chem 283:11866–11875,

2008.

299. Hemmelgarn B, Suissa S, Huang A, et al: Benzodia-

zepine use and the risk of motor vehicle crash in the

elderly. JAMA 278:27, 1997.

300. Mozkowitz MA: Basic mechanisms in vascular

headache. Neurol Clin 8:801, 1990.

301. Michel P, Henry P, Letenneur L, et al: Diagnostic

screen for assessment of IHS criteria for migraine

by general practitioners. Cephalagia 12:54, 1993.

302. MacIntyre PD, Bhargava B, Hogg KJ, et al: Effect of

subcutaneous sumatriptan, a selective 5HT-1

agonist, on the systemic, pulmonary, and coronary

circulation. Circulation 87:401, 1993.

303. Shadick NA, Phillips CB, Logigian EL, et al: The

long-term clinical outcomes of Lyme disease. A

population-based retrospective cohort study. Ann

Intern Med 121:560, 1994.

304. Ferguson RJ, Caplan LR: Cervical spondylitic mye-

lopathy. Neurol Clin 3:373, 1985.

305. Ovassapian A, Land P, Schafer MF, et al: Anesthetic

management for surgical corrections of severe

flexion deformity of the cervical spine. Anesthesio-

logy 58:370, 1983.

Implicaciones anestésicas de las enfermedades concurrentes

911

Sección III

Control de la anestesia